Enduring Material

• Understanding appropriate diagnosis of psoriatic disease in skin of color and underserved from a cross-disciplinary perspective
• Outlining the safety, efficacy, and role of current and emerging treatments in addressing both skin and joint symptoms for psoriasis and psoriatic arthritis
• Addressing comorbid conditions in diverse populations and in specific regions of the United States
• Applying a patient-centric, collaborative care and appropriate shared management model for treatment of psoriatic disease in patients

Dermatology/Rheumatology Collaborative with a Focus in Skin of Color in partnership with PPACMAN and supported by Abbvie.

• Seemal R. Desai, MD, FAAD
• Sheetal Desai, MD - UC Irvine
• Erin Boh, MD, PhD, FAAD
• Niti Goel, MD
• Junko Takeshita, MD, PhD, MSCE, FAAD
• Paras Karmacharya, MD, MS
• Tiffany Mayo, MD, MS, FAAD

• The National Psoriasis Foundation designates this enduring material for a maximum of 2 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
• The National Psoriasis Foundation designates this enduring material for a maximum of 2 Hour(s) Attendance w/ No Credit. Participants should claim only the credit commensurate with the extent of their participation in the activity.

Dermatology/Rheumatology Collaborative with a Focus on Skin of Color

Erin Boh, MD, PhD, FAAD and Paras Karmacharya, MD, MS have no financial relationship(s) with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients to disclose.

Seemal R. Desai, MD, FAAD has disclosed a financial relationship with one or more ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients:

• AbbVie - Contracted Research
• Galderma Laboratories, LP - Consulting
• Cassiopea SpA - Consulting
• Ortho Dermatologics - Consulting
• Ortho Dermatologics - Consulting
• SkinCeuticals LLC - Consulting
• Dermira - Consulting
• Foundation for Research & Education of Dermatology - Advisory Committee Member
• Almirall - Consulting
• Almirall - Speaking
• Dermavant - Advisory Committee Member
• Scientis - Consulting
• Sente Labs - Consulting
• Foamix - Consulting
• Pfizer - Consulting
• Verrica Pharmaceuticals Inc - Consulting
• Atacama Therapeutics - Investigator
• Ferndale Laboratories, Inc. - Consulting
• Incyte Corporation - Investigator
• Gore Range Capital - Stockholder
• Gore Range Capital - Consulting
• Incyte Corporation - Consulting
• Dermavant Sciences - Investigator
• AOBiome, LLC - Investigator
• Brickell Biotech, Inc - investigator
• BMS - Consulting
• UCB - Consulting
• Galderma Laboratories, LP - Speaking
• EPI Health - Consulting

Sheetal Desai, MD has disclosed a financial relationship with one or more ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients:

• Janssen - Speakers Bureau - Relationship Has Not Ended

Niti Goel, MD has disclosed a financial relationship with one or more ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients:

• UCB - Stock - Relationship Has Not Ended

Tiffany Mayo, MD, MS, FAAD has disclosed a financial relationship with one or more ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients:

• Lilly - Advisory Committee Member - Relationship Has Not Ended
• ChemoCentryx - Principal Investigator - Relationship Has Not Ended
• Janssen - Advisory Committee Member - Relationship Has Not Ended
• Novartis - Advisory Committee Member - Relationship Has Not Ended
• Pfizer - Advisory Committee Member - Relationship Has Not Ended

Junko Takeshita, MD, PhD, MSCE, FAAD has disclosed a financial relationship with one or more ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients:

• Pfizer - Consulting - Relationship Has Not Ended
• Janssen - Consulting - Relationship Has Not Ended

• The National Psoriasis Foundation is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

0 %

100 %

1/5/2022